BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 20228513)

  • 1. The role of theophylline in prevention of radiocontrast media-induced nephropathy.
    Malhis M; Al-Bitar S; Al-Deen Zaiat K
    Saudi J Kidney Dis Transpl; 2010 Mar; 21(2):276-83. PubMed ID: 20228513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of theophylline in preventing contrast-induced nephropathy after coronary angiographic procedures.
    Bilasy ME; Oraby MA; Ismail HM; Maklady FA
    J Interv Cardiol; 2012 Aug; 25(4):404-10. PubMed ID: 22612071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium bicarbonate, N-acetylcysteine, and saline for prevention of radiocontrast-induced nephropathy. A comparison of 3 regimens for protecting contrast-induced nephropathy in patients undergoing coronary procedures. A single-center prospective controlled trial.
    Ozcan EE; Guneri S; Akdeniz B; Akyildiz IZ; Senaslan O; Baris N; Aslan O; Badak O
    Am Heart J; 2007 Sep; 154(3):539-44. PubMed ID: 17719303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-acetylcysteine versus N-acetylcysteine + theophylline for the prevention of contrast nephropathy.
    Baskurt M; Okcun B; Abaci O; Dogan GM; Kilickesmez K; Ozkan AA; Ersanli M; Gurmen T
    Eur J Clin Invest; 2009 Sep; 39(9):793-9. PubMed ID: 19500141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sodium bicarbonate versus saline for the prevention of contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention.
    Maioli M; Toso A; Leoncini M; Gallopin M; Tedeschi D; Micheletti C; Bellandi F
    J Am Coll Cardiol; 2008 Aug; 52(8):599-604. PubMed ID: 18702961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium bicarbonate versus normal saline for protection against contrast nephropathy.
    Budhiraja P; Chen Z; Popovtzer M
    Ren Fail; 2009; 31(2):118-23. PubMed ID: 19212908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of theophylline on contrast material-nephropathy in patients with chronic renal insufficiency: controlled, randomized, double-blinded study.
    Huber W; Ilgmann K; Page M; Hennig M; Schweigart U; Jeschke B; Lutilsky L; Weiss W; Salmhofer H; Classen M
    Radiology; 2002 Jun; 223(3):772-9. PubMed ID: 12034949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The incidence of contrast-induced nephropathy in trauma patients.
    Hipp A; Desai S; Lopez C; Sinert R
    Eur J Emerg Med; 2008 Jun; 15(3):134-9. PubMed ID: 18460952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sodium chloride vs. sodium bicarbonate for the prevention of contrast medium-induced nephropathy: a randomized controlled trial.
    Klima T; Christ A; Marana I; Kalbermatter S; Uthoff H; Burri E; Hartwiger S; Schindler C; Breidthardt T; Marenzi G; Mueller C
    Eur Heart J; 2012 Aug; 33(16):2071-9. PubMed ID: 22267245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of usefulness of sodium bicarbonate versus sodium chloride to prevent contrast-induced nephropathy in patients undergoing an emergent coronary procedure.
    Masuda M; Yamada T; Mine T; Morita T; Tamaki S; Tsukamoto Y; Okuda K; Iwasaki Y; Hori M; Fukunami M
    Am J Cardiol; 2007 Sep; 100(5):781-6. PubMed ID: 17719320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevention of contrast-induced nephropathy using cardiac catheterization combined with hydration, oral N-acetylcysteine, sodium bicarbonate and iso-osmolar contrast agents].
    Hoshino A; Enomoto S; Kawahito H; Kurata H; Nakahara Y; Nakamura T
    J Cardiol; 2007 Aug; 50(2):119-26. PubMed ID: 17802695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins for prevention of contrast-induced nephropathy in patients undergoing non-emergent percutaneous coronary intervention.
    Kandula P; Shah R; Singh N; Markwell SJ; Bhensdadia N; Navaneethan SD
    Nephrology (Carlton); 2010 Mar; 15(2):165-70. PubMed ID: 20470274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylaxis of contrast material-induced nephropathy in patients in intensive care: acetylcysteine, theophylline, or both? A randomized study.
    Huber W; Eckel F; Hennig M; Rosenbrock H; Wacker A; Saur D; Sennefelder A; Hennico R; Schenk C; Meining A; Schmelz R; Fritsch R; Weiss W; Hamar P; Heemann U; Schmid RM
    Radiology; 2006 Jun; 239(3):793-804. PubMed ID: 16714461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of contrast-induced nephropathy: the rational use of sodium bicarbonate.
    Barreto R
    Nephrol Nurs J; 2007; 34(4):417-21. PubMed ID: 17891910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acetylcysteine in the prevention of contrast-induced nephropathy after coronary angiography.
    Oldemeyer JB; Biddle WP; Wurdeman RL; Mooss AN; Cichowski E; Hilleman DE
    Am Heart J; 2003 Dec; 146(6):E23. PubMed ID: 14661012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of N-acetylcysteine on cystatin C-based renal function after elective coronary angiography (ENABLE Study): a prospective, randomized trial.
    Kim BJ; Sung KC; Kim BS; Kang JH; Lee KB; Kim H; Lee MH
    Int J Cardiol; 2010 Feb; 138(3):239-45. PubMed ID: 18793808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-acetylcysteine and sodium bicarbonate versus N-acetylcysteine and standard hydration for the prevention of radiocontrast-induced nephropathy following coronary angiography.
    Schmidt P; Pang D; Nykamp D; Knowlton G; Jia H
    Ann Pharmacother; 2007 Jan; 41(1):46-50. PubMed ID: 17190844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of two hemofiltration protocols for prevention of contrast-induced nephropathy in high-risk patients.
    Marenzi G; Lauri G; Campodonico J; Marana I; Assanelli E; De Metrio M; Grazi M; Veglia F; Fabbiocchi F; Montorsi P; Bartorelli AL
    Am J Med; 2006 Feb; 119(2):155-62. PubMed ID: 16443418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced incidence of radiocontrast-induced nephropathy in ICU patients under theophylline prophylaxis: a prospective comparison to series of patients at similar risk.
    Huber W; Jeschke B; Page M; Weiss W; Salmhofer H; Schweigart U; Ilgmann K; Reichenberger J; Neu B; Classen M
    Intensive Care Med; 2001 Jul; 27(7):1200-9. PubMed ID: 11534569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new protocol using sodium bicarbonate for the prevention of contrast-induced nephropathy in patients undergoing coronary angiography.
    Motohiro M; Kamihata H; Tsujimoto S; Seno T; Manabe K; Isono T; Sutani Y; Yuasa F; Iwasaka T
    Am J Cardiol; 2011 Jun; 107(11):1604-8. PubMed ID: 21420053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.